Tetra Radar · FDA Approvals · Decision date

rapamycin: FDA decision date

Ligand Pharmaceuticals Inc (LGND) · 28 February 2027

The FDA has assigned a Prescription Drug User Fee Act (PDUFA) target action date of February 28, 2027.

Source: 10-Q of 30 October 2026

The decision is pending.

A PDUFA date is the date by which the FDA has said it will decide on an application. Dates can move, and a decision is not an approval. Tetra Radar observes public information for research purposes. It does not provide investment advice.

Get the Dispatch free.